Delivery Order SPE2DB20D9214-SPE2DB22FD5AJ

Award Date 9/20/22
Potential Completion Date 10/12/22
Potential Value $79K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This contract award is for the delivery of XOLAIR 150 MG/1.2 ML POWDER VLS pharmaceutical products to the Defense Logistics Agency (DLA), a defense agency. The award was made to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is a firm fixed-price delivery order with a ceiling value of $4,642.20 and an ultimate completion date of September 23, 2024. DMS Pharmaceutical Group Inc. holds a significant $499,999,999...
This federal contract award is for the delivery of Xolair 150 mg/ml syringes to the Defense Logistics Agency (DLA), a defense agency. The contract was awarded to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is a firm fixed-price delivery order with a ceiling value of $1,547.40 and an ultimate completion date of March 31, 2025. DMS Pharmaceutical Group Inc. holds a significant single-award Indefinite Delivery...
This federal contract award is a delivery order for $11,605.50 issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the delivery of Xolair 150 mg/ml syringes, a specialized pharmaceutical product, with a completion date of September 7, 2023. DMS Pharmaceutical Group Inc. holds a significant $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the...
This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $18,568.80, is a firm fixed-price delivery order for the supply of Xolair 150 mg/ml syringes. The contract has an ultimate completion date of April 8, 2025. DMS Pharmaceutical Group Inc. holds a significant $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the...
This federal contract award is for the delivery of XOLAIR 300 MG/2 ML AUTOINJECT 2ML to the Defense Logistics Agency (DLA), a defense agency. The $6,848.92 firm fixed-price delivery order was awarded to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract has an ultimate completion date of June 16, 2025. DMS Pharmaceutical Group Inc. holds a $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB...
This federal contract award, valued at $3,094.80, was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is a delivery order for the pharmaceutical product Xolair 150 mg/ml syringe. It is a firm fixed-price contract with a period of performance through February 13, 2025. DMS Pharmaceutical Group Inc. holds a significant $499,999,999 Indefinite Delivery Contract (IDC)...
This federal contract award is for the delivery of XOLAIR 150 MG/1.2 ML POWDER VLS to the Defense Logistics Agency (DLA), a defense agency. The contract was awarded to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract has a ceiling value of $19,838.64 and is a firm fixed-price delivery order with no set-aside designation. DMS Pharmaceutical Group Inc. holds a significant indefinite delivery contract (IDC) with the...
This is a federal contract award from the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is a firm fixed-price delivery order valued at $4,642.20, with a period of performance through February 7, 2025. The contract is for the delivery of Xolair 150 mg/1.2 ml powder vials, a specialized pharmaceutical product. DMS Pharmaceutical Group Inc. holds a significant single-award...
The U.S. Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order contract valued at $4,642.20 to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The contract is for the delivery of Xolair 150 mg/1.2 ml powder for injection. This order is issued under DMS Pharmaceutical Group's existing indefinite delivery vehicle (IDV) contract SPE2DB20D9761, a $4,999,999 single-award contract with DLA that enables the agency to issue delivery orders...
This federal contract award, with ID SPE2DB20D9127 and SPE2DB22FD3XQ, was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $79,168.32 delivery order is for Xolair 150 mg/1.2 ml powder vials and is a firm fixed-price contract. DMS Pharmaceutical Group holds a $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, which enables the DLA to issue...
  • SPE2DB20D9214
    Indefinite Delivery Contract
  • SPE2DB20D9214-SPE2DB22FD5AJ
    Delivery Order

This federal contract award is for the delivery of Xolair 150 mg/1.2 ml powder vials to the Defense Logistics Agency (DLA), a defense agency. The contract was awarded to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $79,168.32 firm fixed-price delivery order contract has an ultimate completion date of October 12, 2022.

DMS Pharmaceutical Group Inc. holds a significant $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, which allows the agency to issue delivery orders for a comprehensive range of pharmaceutical products to support the medical supply needs of military health facilities worldwide. This contract award is part of that larger IDC vehicle, which covers branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables across various product categories.

Generated 4/1/25, 8:15 PM